The breakthrough in vitro transcribed (IVT) RNA innovation that researchers utilized during the COVID-19 pandemic paved the way for mRNA vaccine advancement to deal with other transmittable diseases. During IVT vaccine production, scientists produce synthetic pathogen genome sequences wholesale. During this process, utilizing robust nucleic acid quality assurance testing ends up being important to check the purity and stability of the final vaccine product.
Download this white paper from Agilent to learn more about the history of vaccine advancement, milestones in mRNA research, and the function of electrophoresis systems in mRNA vaccine development.
For Research Use Only. Not for use in diagnostic procedures.
.
